Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit Medical Dialogues Bureau20 July 2019 9:52 AM ISTZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...
Cabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities Medical Dialogues Bureau19 July 2019 3:03 PM ISTNEW DELHI: The Union Cabinet Wednesday approved loans of Rs 330.35 crore to three state-owned pharma companies to help them clear employees'...
Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit Medical Dialogues Bureau19 July 2019 3:02 PM ISTAbbott Laboratories beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump...
DOP rejects Mylan review application for revising retail price of Hepatitis B, HIV drug Farhat Nasim18 July 2019 3:58 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals has rejected the review application filed by Mylan Pharmaceuticals Private...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Novartis sickle cell drug crizanlizumab secures speedy USFDA review Medical Dialogues Bureau17 July 2019 9:26 AM ISTNovartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
USFDA issues warning letter to Indoco Remedies for Goa plant Medical Dialogues Bureau16 July 2019 11:39 AM ISTThe facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
Natco Pharma gets zero USFDA observations for Chennai facility Medical Dialogues Bureau16 July 2019 9:30 AM ISTNatco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat Farhat Nasim15 July 2019 2:52 PM ISTNew Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US Farhat Nasim15 July 2019 2:40 PM ISTEzallor Sprinkle (rosuvastatin) capsules are indicated for three types of lipid disorders in conjunction with diet in adults, Sun Pharma said in a...
Lupin to focus on launch of biosimilar, inhalation product in US this fiscal Medical Dialogues Bureau15 July 2019 9:45 AM ISTCoupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they...
Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report Medical Dialogues Bureau15 July 2019 9:30 AM ISTThe deal is the largest Gilead has executed since new Chief Executive Officer Dan O'Day took the reins in March as he attempts to bolster the San...
